Evidence map›Paper›PMID 36515858›Full record

ReviewMolecular biotechnology2024

Towards Small Scale: Overview and Applications of Microfluidics in Biotechnology.

Anton Enders, Alexander Grünberger, Janina Bahnemann

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Biocatalytic Performance ofMicromachines · 2024
    Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anton EndersInstitute of Technical Chemistry, Leibniz University Hannover, Callinstraße 5, 30167, Hannover, Germany.
Alexander GrünbergerInstitute of Process Engineering in Life Sciences: Microsystems in Bioprocess Engineering, Karlsruhe Institute of Technology, Fritz-Haber-Weg 2, 76131, Karlsruhe, Germany.
Janina BahnemannInstitute of Physics, University of Augsburg, Universitätsstraße 1, 86159, Augsburg, Germany. janina.bahnemann@uni-a.de.ORCID http://orcid.org/0000-0002-7008-1673
Karlsruhe Institute of Technology · DELeibniz University Hannover · DEUniversity of Augsburg · DE

Funding

German Research Foundation (DFG) 346772917 Emmy Noether Programme
6 · The paper itself

Abstract

Thanks to recent and continuing technological innovations, modern microfluidic systems are increasingly offering researchers working across all fields of biotechnology exciting new possibilities (especially with respect to facilitating high throughput analysis, portability, and parallelization). The advantages offered by microfluidic devices-namely, the substantially lowered chemical and sample consumption they require, the increased energy and mass transfer they offer, and their comparatively small size-can potentially be leveraged in every sub-field of biotechnology. However, to date, most of the reported devices have been deployed in furtherance of healthcare, pharmaceutical, and/or industrial applications. In this review, we consider examples of microfluidic and miniaturized systems across biotechnology sub-fields. In this context, we point out the advantages of microfluidics for various applications and highlight the common features of devices and the potential for transferability to other application areas. This will provide incentives for increased collaboration between researchers from different disciplines in the field of biotechnology.

Indexed as

BiotechnologyMicrofluidicsBiochemical engineeringIndustrial biotechnologyLab-on-a-chipMedical biotechnologyMicrofluidicsMicrofluidic screeningNanofluidicsOrgan-on-a-chipPoint-of-carePoint-of-use

Identifiers

PMID36515858
PMCPMC10881759
OpenAlexW4311473474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.